Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Compass Pathways Plc ADR (CMPS)

Compass Pathways Plc ADR (CMPS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,584,423
  • Shares Outstanding, K 39,930
  • Annual Sales, $ 0 K
  • Annual Income, $ -60,330 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.66
Trade CMPS with:

Options Overview

Details
  • Implied Volatility 63.89%
  • Historical Volatility 48.07%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 314.68% on 12/18/20
  • IV Low 63.89% on 06/11/21
  • Put/Call Vol Ratio 0.29
  • Today's Volume 371
  • Volume Avg (30-Day) 923
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 13,344
  • Open Int (30-Day) 11,482

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.33
  • Number of Estimates 3
  • High Estimate -0.30
  • Low Estimate -0.36
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.02 +23.93%
on 05/13/21
40.41 -1.81%
on 06/10/21
+4.10 (+11.52%)
since 05/11/21
3-Month
31.89 +24.43%
on 04/21/21
43.77 -9.34%
on 03/17/21
-1.24 (-3.03%)
since 03/11/21

Most Recent Stories

More News
Psilocybin Could Help Treat Nearly 264 Million with Depression

Mental health is on the decline all over the world. In fact, as you read this, nearly 264 million ...

FTRPF : 5.2000 (+2.97%)
MNMD : 3.92 (+8.29%)
CMPS : 39.68 (+0.71%)
KONEF : 1.5420 (-0.52%)
FTRP.CN : 5.550 (+1.46%)
MYND.CN : 2.050 (-2.38%)
Why the North America Psychedelic Drugs Market is Expected to Grow With the Fastest CAGR for Next Several Years

/PRNewswire/ -- The illegal drugs of the 1960's are becoming highly valued drugs for various new therapeutic uses across a growing list of maladies. The door of previously prohibited drugs has been opening...

SILO : 0.2846 (-1.79%)
CMPS : 39.68 (+0.71%)
MNMD : 3.92 (+8.29%)
CLXPF : 1.5297 (+3.36%)
LKYSF : 0.8500 (+1.25%)
NUMI.VN : 1.030 (+0.98%)
OPTI.CN : 0.700 (-2.78%)
OPTHF : 0.5875 (-0.94%)
COMPASS Pathways plc to participate in JMP Securities and H.C. Wainwright investor conferences

COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that members of its management...

CMPS : 39.68 (+0.71%)
COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers

LONDON, June 03, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) ("COMPASS"), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental...

CMPS : 39.68 (+0.71%)
A New ETF Launches for Next-Gen Medicine

According to a report from ResearchAndMarkets, the global psychedelic drugs market could be worth $10.75 ...

CWEB.TO : 5.35 (+1.90%)
ACB.TO : 11.94 (-0.33%)
MNMD : 3.92 (+8.29%)
PSY : 27.68 (+0.91%)
CWEB : 45.08 (-1.20%)
ACB : 9.82 (-0.71%)
CMPS : 39.68 (+0.71%)
With Psychedelics, Mental Health Care May Never be the Same

With psychedelics, mental health care may never be the same. All as some of the nation’s “top ...

CLXPF : 1.5297 (+3.36%)
MMEDF : 4.6900 (+33.24%)
CMPS : 39.68 (+0.71%)
NMDBF : 0.1192 (-3.95%)
TRYP.CN : 0.570 (unch)
NEON.CN : 0.145 (unch)
Psychedelic Drug Market Has Become a Billion Dollar Industry As Acceptable Treatments Expand

, /PRNewswire/ -- Recently, the use of psychedelics is evolving for the treatment of a variety of mental illnesses, including anxiety, depression, post-traumatic stress disorder and other related uses....

LKYSF : 0.8500 (+1.25%)
SILO : 0.2846 (-1.79%)
CMPS : 39.68 (+0.71%)
MNMD : 3.92 (+8.29%)
NUMI.VN : 1.030 (+0.98%)
CLXPF : 1.5297 (+3.36%)
Down 25% YTD, Should Investors Scoop Up Shares of COMPASS Pathways?

Healthcare companies are continuously looking for new treatment options for patients. One in particular, COMPASS Pathways (CMPS), is focused on using psilocybin therapy treat depression. The stock has...

CMPS : 39.68 (+0.71%)
Wall Street Unicorns in Process of Changing the Healthcare Landscape

, /PRNewswire/ -- Before 1970, promising research was being conducted on the potential therapeutic effects of a broad category of psychedelic drug compounds, including substances such as psilocybin, DMT...

TRYP.CN : 0.570 (unch)
TRYPF : 0.4809 (+0.19%)
CMPS : 39.68 (+0.71%)
FTRPF : 5.2000 (+2.97%)
FTRP.CN : 5.550 (+1.46%)
CLXPF : 1.5297 (+3.36%)
MNMD : 3.92 (+8.29%)
The World May be Closer to Better Treatments for Parkinson’s Disease

Nearly 10 million people struggle with Parkinson’s disease at the moment.While there is no cure ...

MNMD : 3.92 (+8.29%)
CMPS : 39.68 (+0.71%)
SEEL : 3.36 (+0.60%)
CLXPF : 1.5297 (+3.36%)
PHRRF : 0.4929 (+0.59%)
PHRM.CN : 0.610 (+3.39%)

Business Summary

COMPASS Pathways plc is a mental health care company. It operates principally in New York, USA. COMPASS Pathways plc is headquartered in London, UK.

See More

Key Turning Points

3rd Resistance Point 41.65
2nd Resistance Point 40.83
1st Resistance Point 40.25
Last Price 39.68
1st Support Level 38.85
2nd Support Level 38.03
3rd Support Level 37.45

See More

Last Price 39.68
52-Week High N/A
Fibonacci 61.8% 46.72
Fibonacci 50% 42.10
Fibonacci 38.2% 37.48
52-Week Low N/A

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar